You are viewing an incomplete version of our website. Please click to reload the website as full version.

BH3 Interacting Domain Death Agonist (BID) (C-Term) Peptide

Details for Product No. ABIN1382203, Supplier: Login to see New
New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms BID, bid, si:ch211-238n5.6, fp497, xbid, DKFZp469E066, FP497, 2700049M22Rik, AI875481, AU022477
Protein Region
C-Term
Origin
Human
(12), (7), (1)
Application
Blocking Peptide (BP)
Pubmed 3 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 0.05 mg
Shipping to United States ( )
Availability Will be delivered in 2 to 3 Business Days
Blocked Antibody anti-BID antibody (BH3 Interacting Domain Death Agonist) (C-Term) (ABIN1030296)
Characteristics 14 amino acids near the carboxy terminus of human Bid.
Human
Research Area Cancer, Apoptosis/Necrosis
Application Notes Bid peptide is used for blocking the activity of Bid.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications ONeill, Fitzgerald, Bowie: "The Toll-IL-1 receptor adaptor family grows to five members." in: Trends in immunology, Vol. 24, Issue 6, pp. 286-90, 2003 (PubMed).

Janeway, Medzhitov: "Innate immune recognition." in: Annual review of immunology, Vol. 20, pp. 197-216, 2002 (PubMed).

Wang, Yin, Chao et al.: "BID: a novel BH3 domain-only death agonist." in: Genes & development, Vol. 10, Issue 22, pp. 2859-69, 1996 (PubMed).

Catalog No. ABIN1382203
$93.50
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)